EASTLAND JULIA MARIE
SEC insider (Form 3/4/5 filer). CIK 0001500189. Director at Lantheus Holdings, Inc. (LNTH) and 1 other issuer. 9 reported Form 4/5 transactions since Sep 2024; latest on May 14, 2026. Located in SAN DIEGO, CA.
Companies EASTLAND JULIA MARIE has filed insider reports for
- Lantheus Holdings, Inc. (LNTH): Director
- Zentalis Pharmaceuticals, Inc. (ZNTL): Director, Officer, CEO & President
EASTLAND JULIA MARIE
CIK: 0001500189
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 14, 2026LNTH
Lantheus Holdings, Inc.
AwardDirect4.1K shares- - Feb 9, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect889 shares at avg. $2.39$2K - Feb 6, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
SaleDirect7.9K shares at avg. $2.43$19K - Jan 8, 2026ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
775K shares- - May 14, 2025LNTH
Lantheus Holdings, Inc.
AwardDirect2.5K shares- - Feb 3, 2025ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirect59.4K shares- - Jan 31, 2025ZNTL
Zentalis Pharmaceuticals, Inc.
PurchaseDirect28.5K shares at avg. $1.73$49K - Dec 2, 2024ZNTL
Zentalis Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
3M shares- - Sep 10, 2024LNTH
Lantheus Holdings, Inc.
AwardDirect1.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 14, 2026 |  LNTH Lantheus Holdings, Inc. | Award | 4,137 | - | $0 | Direct |
| Feb 9, 2026 |  ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 889 | $2.39 | $2,127 | Direct |
| Feb 6, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Sale | 7,866 | $2.43 | $19,112 | Direct |
| Jan 8, 2026 | ZNTL Zentalis Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 775,000 | - | - | Direct |
| May 14, 2025 | LNTH Lantheus Holdings, Inc. | Award | 2,537 | - | - | Direct |
| Feb 3, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Award | 59,388 | - | - | Direct |
| Jan 31, 2025 | ZNTL Zentalis Pharmaceuticals, Inc. | Purchase | 28,500 | $1.73 | $49,345 | Direct |
| Dec 2, 2024 | ZNTL Zentalis Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 3,028,800 | - | - | Direct |
| Sep 10, 2024 | LNTH Lantheus Holdings, Inc. | Award | 1,345 | - | $0 | Direct |
1-9 of 9 transactions